BsUFA III Negotiations Nearly Done; Commitment Letter Being Written

 
• By Derrick Gingery
  
FDA website
When BsUFA III talks end, only the generic drug user fee reauthorization negotiations will remain ongoing • Source: Alamy

More from Biosimilars

More from Products